Economic costs of diabetes in the U.S. in 2007

American Diabetes Association·2008·Diabetes Care

Cited by (1,001)

Items 301–400 of 1,001

  1. Emerging technologies for the prevention and management of diabetic foot ulcers
    Chi-Wen Lung, Fu-Lien Wu, Fuyuan Liao, Fang Pu, Yubo Fan, Yih‐Kuen Jan · 2020 · Journal of Tissue Viability
  2. Mobile diabetes intervention study: Testing a personalized treatment/behavioral communication intervention for blood glucose control
    Charlene Connolly Quinn, Ann L. Gruber‐Baldini, Michelle D Shardell, Kelly Weed, Suzanne Sysko Clough, Malinda Peeples, Michael L. Terrin, Lauren Bronich-Hall, Erik A. Barr, Dan Lender · 2009 · Contemporary Clinical Trials
  3. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005—a register‐based approach
    Kristian Bolin, Christina Gip, Ann‐Christin Mörk, Björn Lindgren · 2009 · Diabetic Medicine
  4. Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes
    Eleni I. Boutati, S. Raptis · 2009 · Diabetes Care
  5. Direct and indirect costs among employees with diabetic retinopathy in the United States
    Lauren J. Lee, Andrew Peng Yu, Kevin E. Cahill, Alan K. Oglesby, Jackson Tang, Ying Qiu, Howard G. Birnbaum · 2008 · Current Medical Research and Opinion
  6. The Effect of Diabetes on Hospital Readmissions
    Kathleen Marie Dungan · 2012 · Journal of Diabetes Science and Technology
  7. The impact of treatment non-compliance on mortality in people with type 1 diabetes
    Craig J. Currie, Mark F. Peyrot, Christopher Ll. Morgan, Chris Poole, Sara Jenkins‐Jones, Richard R. Rubin, Christopher M. Burton, Marc Evans · 2012 · Journal of Diabetes and its Complications
  8. Sex Disparities in Diabetes Process of Care Measures and Self-Care in High-Risk Patients
    Margaret K. Yu, Courtney Rees Lyles, Luis A. Bent-Shaw, Bessie Ann Young · 2013 · Journal of Diabetes Research
  9. Sirtuins as novel players in the pathogenesis of diabetes mellitus
    Kültiğin Türkmen · 2014 · World Journal of Diabetes
  10. Inpatient to Outpatient Transfer of Diabetes Care: Planning for an Effective Hospital Discharge
    Curtiss Bela Cook, Karen M. Seifert, Bryan P. Hull, Michael J. Hovan, Joseph C. Charles, Victoria Miller-Cage, Mary E. Boyle, Jana K. Harris, Janice M. Magallanez, Stephanie D. Littman · 2009 · Endocrine Practice
  11. Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS)
    Anna Ringborg, Claire Cropet, Bengt Jönsson, Juan José Gagliardino, Ambady Ramachandran, Peter Lindgren · 2009 · International Journal of Clinical Practice
  12. Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine
    Rosalind P. Fabunmi, Loretta L. Nielsen, Ralph A. Quimbo, Brock E. Schroeder, Derek A. Misurski, Matthew E. Wintle, Ron Wade · 2009 · Current Medical Research and Opinion
  13. Relationship among social support, treatment adherence and metabolic control of diabetes mellitus patients
    Lílian Cristiane Gomes, Milton César Foss, Maria Cristina Foss‐Freitas, Ana Emília Pace · 2012 · Revista Latino-Americana de Enfermagem
  14. Epidemiology and costs of diabetes mellitus in Switzerland: an analysis of health care claims data, 2006 and 2011
    Carola A. Huber, Matthias M. Schwenkglenks, Roland Rapold, Oliver Reich · 2014 · BMC Endocrine Disorders
  15. History of Diabetes and risk of head and neck cancer: a pooled analysis from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium
    M. Stott-Miller, C. Chen, S. Chuang, Y. Lee, S. Boccia, H. Brenner, G. Cadoni, L. Dal Maso, C. la Vecchia, P. Lazarus et al. · 2011 · Cancer Epidemiology, Biomarkers and Prevention
  16. Efficacy of Aloe Vera Supplementation on Prediabetes and Early Non-Treated Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yiyi Zhang, Wen Liu, Dan Liu, Tie-yun Zhao, Haoming Tian · 2016 · Nutrients
  17. Direct Medical Cost of Type 2 Diabetes in Singapore
    Charmaine Shuyu Ng, Matthias Paul Han Sim Toh, Yu Ko, Joyce Yu-Chia Lee · 2015 · PLoS ONE
  18. Liraglutide: A Once-Daily Incretin Mimetic for the Treatment of Type 2 Diabetes Mellitus
    Joshua J. Neumiller, R. Keith Campbell · 2009 · Annals of Pharmacotherapy
  19. Building Capacity to Reduce Disparities in Diabetes
    Kathleen Colleran, Erika Harding, Billie Jo Kipp, Andrea Zurawski, Barbara MacMillan, Lucie Jelínková, Summers G. Kalishman, Denise Dion, Dara Som, Sanjeev Arora · 2012 · The Science of Diabetes Self-Management and Care
  20. The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes
    Sherita Hill Golden, Nisa M. Maruthur, Nestoras Nicolas Mathioudakis, Elias K. Spanakis, Daniel J. Rubin, Mihail F Zilbermint, Felicia Hill‐Briggs · 2017 · Current Diabetes Reports
  21. How Do Type 2 Diabetes Mellitus-Related Chronic Complications Impact Direct Medical Cost in Four Major Cities of Urban China?
    Weibing Wang, Chaowei Fu, Chang Yu Pan, Weiqing Chen, Siyan Zhan, Rongsheng Luan, Alison Tan, Zhaolan Liu, Biao Xu · 2009 · Value in Health
  22. Inpatient Management of Hyperglycemia and Diabetes
    Vasudev Magaji, Jann M. Johnston · 2011 · Clinical Diabetes
  23. The cost of type 1 diabetes: a nationwide multicentre study in Brazil
    Roberta Arnoldi Cobas, Marcos Bosi Ferraz, Alessandra Saldanha de Mattos Matheus, Lucianne Righeti Monteiro Tannus, Carlos Antônio Negrato, Luiz Antônio de Araújo, Sérgio Atala Dib, Marília Brito Gomes, for the Brazilian Type 1 Diabetes Study Group · 2013 · Bulletin of the World Health Organization
  24. Costs of diabetes and its complications in Poland
    Joanna Leśniowska, Agata Schubert, Michał Wojna, Iwona Skrzekowska-Baran, Marta Fedyna · 2013 · The European Journal of Health Economics
  25. The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study
    Gordon Goodall, Eric Sarpong, Clarice Hayes, William J. Valentine · 2009 · BMC Endocrine Disorders
  26. Racial/Ethnic- and Education-Related Disparities in the Control of Risk Factors for Cardiovascular Disease Among Individuals With Diabetes
    Pinka Chatterji, Heesoo Joo, Kajal Lahiri · 2011 · Diabetes Care
  27. Dietary strategies for patients with type 2 diabetes in the era of multi-approaches; review and results from the Dietary Intervention Randomized Controlled Trial (DIRECT)
    Ben-Avraham, Sivan, Harman-Boehm, Ilana, Schwarzfuchs, Dan, Shai, Iris · 2009 · Diabetes Research and Clinical Practice
  28. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus — natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature
    Moshe Vardi, Shany Blum, Andrew P. Levy · 2012 · European Journal of Internal Medicine
  29. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting
    Elise M. Pelletier, Paula Smith, Kristina Secnik Boye, Derek A. Misurski, Sandra L. Tunis, Michael E. Minshall · 2008 · Applied Health Economics and Health Policy
  30. The Effect of Serious Mental Illness on the Risk of Rehospitalization Among Patients With Diabetes
    Lydia Chwastiak, Dimitry S. Davydow, Christine L. McKibbin, Ellen A. Schur, Mason H. Burley, Michael G. McDonell, John M. Roll, Kenn B. Daratha · 2013 · Psychosomatics
  31. Factors Associated with Federal Transportation Funding for Local Pedestrian and Bicycle Programming and Facilities
    Angie L.I. Cradock, Philip J. Troped, Billy Fields, Steven J. Melly, Shannon V Simms, Franz K. Gimmler, Marianne Fowler · 2009 · Journal of Public Health Policy
  32. Mobile Diabetes Intervention for Glycemic Control in 45- to 64-Year-Old Persons With Type 2 Diabetes
    Charlene Connolly Quinn, Michelle D Shardell, Michael L. Terrin, Erik A. Barr, DoHwan Park, Faraz Shaikh, Jack M. Guralnik, Ann L. Gruber‐Baldini · 2014 · Journal of Applied Gerontology
  33. Use of concentrated insulin human regular (U-500) for patients with diabetes
    Alissa R. Segal, Jack E. Brunner, F. Taylor Burch, Jeffrey A. Jackson · 2010 · American Journal of Health-System Pharmacy
  34. The Economics of Diabetes Prevention
    William H. Herman · 2011 · Medical Clinics of North America
  35. Point-of-care diagnostics: an advancing sector with nontechnical issues
    David Huckle · 2008 · Expert Review of Molecular Diagnostics
  36. Secular Trends in Diabetes-Related Preventable Hospitalizations in the United States, 1998–2006
    Jing Wang, Kumiko Imai, Michael Maurice Engelgau, Linda S. Geiss, Christina Wen, Ping Zhang · 2009 · Diabetes Care
  37. Saxagliptin: A Clinical Review in the Treatment of Type 2 Diabetes Mellitus
    Deanna S. Kania, Jasmine D. Gonzalvo, Zach Weber · 2011 · Clinical Therapeutics
  38. Development of the CANRISK questionnaire to screen for prediabetes and undiagnosed type 2 diabetes
    Janusz A. Kaczorowski, Chris A. Robinson, Kara A. Nerenberg · 2009 · Canadian Journal of Diabetes
  39. Comorbidity Status and Annual Total Medical Expenditures in U.S. Hypertensive Adults
    Chanhyun Park, Jing Fang, Nikki A. Hawkins, Guijing Wang · 2017 · American Journal of Preventive Medicine
  40. The Cost of Diabetes-Related Complications: Registry-Based Analysis of Days Absent from Work
    Jan Rose Sørensen, Uffe Jon Ploug · 2013 · Economics Research International
  41. Screening for Type 2 Diabetes in Obese Youth
    Shuchi Shah, Bassil M. Kublaoui, Jon David Oden, Perrin C. White · 2009 · PEDIATRICS
  42. Progression and Regression: Distinct Developmental Patterns of Diabetic Retinopathy in Patients With Type 2 Diabetes Treated in the Diabetes Care System West-Friesland, the Netherlands
    Hata Zavrelova, Trynke Hoekstra, Marjan Alssema, Laura M.C. Welschen, Giel Nijpels, Annette C. Moll, Henrica C. W. de Vet, Bettine C. P. Polak, Jacqueline M. Dekker · 2011 · Diabetes Care
  43. Heberprot-P: a novel product for treating advanced diabetic foot ulcer
    Jorge Berlanga, José I. Fernández, Ernesto López, Pedro A. López, Amaurys del Río, Carmen Valenzuela, Julio Baldomero, Verena Muzio, Manuel Raı́ces, Ricardo Pereira Silva et al. · 2013 · MEDICC Review
  44. Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study
    Xiang Li, Zhangrong Xu, Linong Ji, Lixin Guo, Jing Liu, Kun Feng, Yushan Xu, Dalong Zhu, Weiping Jia, XinWu Ran et al. · 2018 · Journal of Diabetes Investigation
  45. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: A systematic review and meta-analysis
    Christensen, Merete B., Gotfredsen, Anders, Nørgaard, Kirsten · 2017 · Diabetes/Metabolism Research and Reviews
  46. The effectiveness of footwear as an intervention to prevent or to reduce biomechanical risk factors associated with diabetic foot ulceration: A systematic review
    Aoife Healy, Roozbeh Naemi, Nachiappan Chockalingam · 2013 · Journal of Diabetes and its Complications
  47. Screening for Diabetes and Prediabetes Should Be Cost-Saving in Patients at High Risk
    Ranee Chatterjee, K.M. Venkat Narayan, Joseph Lipscomb, Sandra L. Jackson, Qi Long, Zhu Ming, Lawrence S. Phillips · 2013 · Diabetes Care
  48. Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes
    Anushua Sinha, Mangala Rajan, Thomas J. Hoerger, Len Pogach · 2010 · Diabetes Care
  49. Melatonin Attenuates Contrast-Induced Nephropathy in Diabetic Rats: The Role of Interleukin-33 and Oxidative Stress
    Didem Önk, Oruç Alper Onk, Kültiğin Türkmen, Hüseyin Serkan Erol, Tülin Akarsu Ayazoğlu, Osman Nuri Keleş, Mesut Halici, Ergün Topal · 2016 · Mediators of Inflammation
  50. Assessment of adherence and healthcare costs of insulin device (FlexPen®) versus conventional vial/syringe
    Onur Başer, Jonathan R. Bouchard, Tony DeLuzio, Henry J. Henk, Mark Aagren · 2010 · Advances in Therapy
  51. A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment
    Jean‐Éric Tarride, Robert Borden Hopkins, Gord Blackhouse, James M. Bowen, Matthias Bischof, Camilla von Keyserlingk, Daria J. O’Reilly, Feng Xie, Ron A. Goeree · 2010 · PharmacoEconomics
  52. Is diabetes-specific health literacy associated with diabetes-related outcomes in older adults?
    Takashi Yamashita, Cary S. Kart · 2011 · Journal of Diabetes
  53. Increased Persistency in Medication Use by U.S. Medicare Beneficiaries With Diabetes Is Associated With Lower Hospitalization Rates and Cost Savings
    Bruce Stuart, Jane M. Simoni, Lirong Zhao, JENNIFER T. LLOYD, Jalpa A. Doshi · 2009 · Diabetes Care
  54. Community Engaged Leadership to Advance Health Equity and Build Healthier Communities
    Kisha Braithwaite Holden, Tabia Henry Akintobi, Jammie Mack Hopkins, Allyson S. Belton, Brian S. McGregor, Starla Hairston Blanks, Glenda L. Wrenn · 2015 · Social Sciences
  55. Exposure to Endocrine-Disrupting Chemicals and Type 2 Diabetes Mellitus in Later Life
    Jianyan Lin, Rui‐Xing Yin · 2022 · Exposure and Health
  56. Initial Management of Septic Patients with Hyperglycemia in the Noncritical Care Inpatient Setting
    Philipp Schüetz, Maura Kennedy, Jason M. Lucas, Michael D. Howell, William C. Aird, Donald M. Yealy, Nathan Ivan Shapiro · 2012 · The American Journal of Medicine
  57. The delivery of ambulatory diabetes care to children and adolescents with diabetes
    Catherine Pihoker, Gun Forsander, Joseph I. Wolfsdorf, GEORGEANNA JONES KLINGENSMITH · 2009 · Pediatric Diabetes
  58. Factors Contributing to the Rising National Cost of Glucose-Lowering Medicines for Diabetes During 2005–2007 and 2015–2017
    Xilin Zhou, Sundar S. Shrestha, Hui Shao, Ping Zhang · 2020 · Diabetes Care
  59. Unmet Needs in Hispanic/Latino Patients with Type 2 Diabetes Mellitus
    Kenneth J. Cusi, Gloria L. Ocampo · 2011 · The American Journal of Medicine
  60. Cost and clinical implications of diabetes prevention in an Australian setting: A long-term modeling analysis
    Andrew John Palmer, Daniel M. D. Tucker · 2011 · Primary care diabetes
  61. Hospitalization costs and complications in hospitalized patients with type 2 diabetes mellitus in Beijing, China
    Xiaoyuan Bao, Chao Yang, Kai Fang, Moye Shi, Guo‐Pei Yu, Yonghua Hu · 2016 · Journal of Diabetes
  62. Predictors of all-cause 30 day readmission among Medicare patients with type 2 diabetes
    Jenna M. Collins, Ibrahim M. Abbass, Raymond A. Harvey, Brandon T. Suehs, Claudia Uribe, Jonathan R. Bouchard, TODD G. PREWITT, Tony DeLuzio, Elsie Allen · 2017 · Current Medical Research and Opinion
  63. Economic Costs Attributable to Diabetes in Each U.S. State
    Sundar S. Shrestha, Amanda Honeycutt, Wenya Yang, Ping Zhang, Olga Khavjou, Diana C. Poehler, Simon J. Neuwahl, Thomas J. Hoerger · 2018 · Diabetes Care
  64. A health economic analysis of clinical islet transplantation
    Jessica Beckwith, John A. Nyman, Brian Flanagan, Rudolf Schrover, Henk‐Jan Schuurman · 2011 · Clinical Transplantation
  65. Inflammatory and Angiogenic Abnormalities in Diabetic Wound Healing: Role of Neuropeptides and Therapeutic Perspectives
    Ana Tellechea · 2012 · The Open Circulation & Vascular Journal
  66. Direct Medical Costs for Patients with Type 2 Diabetes and Related Complications: A Prospective Cohort Study Based on the Korean National Diabetes Program
    Tae Ho Kim, Ki Hong Chun, Hae Jin Kim, Seung Jin Han, Dae Jung Kim, Jiyeong Kwak, Young Seol Kim, Jeong‐Taek Woo, Yongsoo Park, Moonsuk Nam et al. · 2012 · Journal of Korean Medical Science
  67. Diabetes Knowledge and Its Relationship With Achieving Treatment Recommendations in a National Sample of People With Type 2 Diabetes
    Sarah Stark Casagrande, Nilka Rı́os Burrows, Linda S. Geiss, Kathleen E. Bainbridge, JUDITH E. FRADKIN, Catherine C. Cowie · 2012 · Diabetes Care
  68. Annual Total Medical Expenditures Associated with Hypertension by Diabetes Status in U.S. Adults
    Guijing Wang, Xilin Zhou, Xiaohui Zhuo, Ping Zhang · 2017 · American Journal of Preventive Medicine
  69. Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study
    Mette Lykke Norgaard, S. S. Andersen, T. K. Schramm, Fredrik Folke, Casper H. Jørgensen, Morten Lock Hansen, Charlotte Andersson, Ditte‐Marie Bretler, Allan Arthur Vaag, Lars Køber et al. · 2010 · Diabetologia
  70. Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes
    Anna Ringborg, Peter Lindgren, Dangyue Yin, Mats Martinell, Jan Stålhammar · 2010 · Diabetes & Metabolism
  71. Impact of Medication Adherence on Absenteeism and Short-Term Disability for Five Chronic Diseases
    Ginger Smith Carls, M. Christopher Roebuck, Troyen A. Brennan, Julie A. Slezak, Olga S. Matlin, Teresa B. Gibson · 2012 · Journal of Occupational and Environmental Medicine
  72. Pré-diabetes: diagnóstico, avaliação de complicações crônicas e tratamento
    Camila Furtado de Souza, Jorge Luiz Gross, Fernando Gerchman, Cristiane Bauermann Leitão · 2012 · Arquivos Brasileiros de Endocrinologia & Metabologia
  73. Common mental disorders associated with 2-year diabetes incidence: The Netherlands Study of Depression and Anxiety (NESDA)
    Atlantis, Evan, Vogelzangs, Nicole, Cashman, Kara, Penninx, Brenda J.W.H. · 2012 · Journal of Affective Disorders
  74. Standardized Glycemic Management with a Computerized Workflow and Decision Support System for Hospitalized Patients with Type 2 Diabetes on Different Wards
    Katharina M. Neubauer, Julia Katharina Mader, Bernhard Höll, Felix Aberer, Klaus Donsa, Thomas Augustin, Lukas A. Schaupp, Stephan Spat, Peter Beck, Friedrich M Fruhwald et al. · 2015 · Diabetes Technology & Therapeutics
  75. Risk factors for hypoglycemia in patients with type 2 diabetes, hospitalized in internal medicine wards: Findings from the FADOI-DIAMOND study
    Vito Borzı̀, Stefania Frasson, Gualberto Gussoni, M. Lillo, Riccardo Gerloni, G. Augello, Giovanni Gulli, Antonio Ceriello, Bruno Solerte, E. Bonizzoni et al. · 2016 · Diabetes Research and Clinical Practice
  76. Bridging the Gap between Theory and Practice in Integrated Care: The Case of the Diabetic Foot Pathway in Tuscany
    Sabina Nuti, Barbara Bini, Tommaso Grillo Ruggieri, Alberto Piaggesi, Lucia Ricci · 2016 · International Journal of Integrated Care
  77. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis
    Robert G. Frykberg, Shawn M. Cazzell, J Arroyo-Rivera, Arthur J. Tallis, Alexander M. Reyzelman, Federica Saba, L. Warren, Bruce C. Stouch, Thomas W. Gilbert · 2016 · Journal of Wound Care
  78. Physical Activity and Electronic Media Use in the SEARCH for Diabetes in Youth Case-Control Study
    Felipe Lobelo, Angela D. Liese, Jihong Liu, Elizabeth J. Mayer‐Davis, Ralph B. D'Agostino, Russell R. Pate, Richard F. Hamman, Dana Dabelea · 2010 · PEDIATRICS
  79. An overview of management issues in adult patients with type 2 diabetes mellitus
    Vigersky, Robert A. · 2011 · Journal of Diabetes Science and Technology
  80. Towards Personalization of Diabetes Therapy Using Computerized Decision Support and Machine Learning: Some Open Problems and Challenges
    Klaus Donsa, Stephan Spat, Peter Beck, Thomas Rudolf Pieber, Andreas Holzinger · 2015 · Lecture notes in computer science
  81. Sphingolipids and Hepatic Steatosis
    Benjamin T. Bikman, Scott A. Summers · 2011 · Advances in experimental medicine and biology
  82. Clinical decision support systems in the care of inpatients with diabetes in non‐critical care setting: systematic review
    Krishnarajah Nirantharakumar, Yen‐Fu Chen, Tom P Marshall, J. Webber, Jamie J. Coleman · 2011 · Diabetic Medicine
  83. The high-cost, type 2 diabetes mellitus patient: an analysis of managed care administrative data
    Juliana Meyers, Shreekant V. Parasuraman, Kelly F. Bell, John P Graham, Sean D. Candrilli · 2014 · Archives of Public Health
  84. Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial
    Lin Y. Chen, J. Thomas Bigger, Kathleen T. Hickey, Haiying Chen, Carlos Lopez-Jimenez, Mary Ann Banerji, Gregory W. Evans, Jerome L. Fleg, Vasilios Papademetriou, Abraham Thomas et al. · 2015 · American Journal of Hypertension
  85. Different strategies for detection of HbA1c emphasizing on biosensors and point-of-care analyzers
    Jagjit Kaur, Cheng Jiang, Guozhen Liu · 2018 · Biosensors and Bioelectronics
  86. Economic burden of diabetic patients in India: A review
    Balasaheb Bansode, Suresh Banayya Jungari · 2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  87. Preventing diabetic complications: A primary care perspective
    Paul Zimmet · 2009 · Diabetes Research and Clinical Practice
  88. Histological and gene expression analysis of the effects of pulsed low-level laser therapy on wound healing of streptozotocin-induced diabetic rats
    Zanelabedien Sharifian, Mohammad Bayat, Morteza Alidoust, Reza Mastery Farahani, Maryam Bayat, Fatemealsadat Rezaie, Homa Bayat · 2013 · Lasers in Medical Science
  89. Addressing hyperglycemia from hospital admission to discharge
    Etie S. Moghissi · 2010 · Current Medical Research and Opinion
  90. In vitro studies evaluating the effects of biofilms on wound‐healing cells: a review
    Kelly R. Kirker, Garth A. James · 2017 · Apmis
  91. Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes
    Greg A. Nichols, Edward J. Moler · 2010 · Diabetologia
  92. Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)
    Jennifer M. Polinski, Seoyoung C. Kim, Dingfeng Jiang, Ahmed Abdul Karim Hassoun, William H. Shrank, Xavier Cos, Efraín Rodríguez-Vigil, Shuichi Suzuki, Ikuro Matsuba, John D. Seeger et al. · 2015 · BMC Endocrine Disorders
  93. Exercise Assessment and Prescription in Patients With Type 2 Diabetes in the Private and Home Care Setting: Clinical Recommendations From AXXON (Belgian Physical Therapy Association)
    Dominique Hansen, Stefaan Peeters, Bruno Zwaenepoel, Dirk Verleyen, Carla Wittebrood, Nicole Timmerman, Michel Schotte · 2013 · Physical Therapy
  94. Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis
    Toni Meier, Karolin Senftleben, Peter Deumelandt, Olaf Christen, Katja Riedel, Martin Langer · 2015 · PLoS ONE
  95. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
    Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo · 2016 · International Journal of Molecular Sciences
  96. Quantifying Dynamic Changes in Plantar Pressure Gradient in Diabetics with Peripheral Neuropathy
    Chi-Wen Lung, Elizabeth T. Hsiao‐Wecksler, Stephanie Burns, Lin Fang, Yih‐Kuen Jan · 2016 · Frontiers in Bioengineering and Biotechnology
  97. Islet Microencapsulation: Strategies and Clinical Status in Diabetes
    Mustafa Omami, James J. McGarrigle, Mick B. Reedy, Douglas Isa, Sofia Ghani, Enza Marchese, Matthew A. Bochenek, Maha Longi, Yuan Xing, Ira Joshi et al. · 2017 · Current Diabetes Reports
  98. Critical role of tissue mast cells in controlling long-term glucose sensor function in vivo
    Klueh, Ulrike, Kaur, Manjot, Qiao, Yi, Kreutzer, Donald L. · 2010 · Biomaterials
  99. Review of vitreous islet cryopreservation
    Michael J. Taylor, Simona Baicu · 2009 · Organogenesis
  100. Ocular Telehealth Screenings in an Urban Community
    Khadija S. Shahid, Anton M. Kolomeyer, Natasha V. Nayak, Nura Salameh, Gina Pelaez, Albert S Khouri, Thomas T. Eck, Ben C. Szirth · 2012 · Telemedicine Journal and e-Health